Effects of anti-PD-1 immunotherapy on tumor regression: insights from a patient-derived xenograft model
出版年份 2020 全文链接
标题
Effects of anti-PD-1 immunotherapy on tumor regression: insights from a patient-derived xenograft model
作者
关键词
-
出版物
Scientific Reports
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-04-27
DOI
10.1038/s41598-020-63796-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: Results From the CA209-003 Study
- (2018) Scott Gettinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiologic Pseudoprogression during Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer
- (2018) Sharyn I. Katz et al. Journal of Thoracic Oncology
- NETs detection and quantification in paraffin embedded samples using confocal microscopy
- (2018) A. Santos et al. MICRON
- HDAC1 interacts with the p50 NF-κB subunit via its nuclear localization sequence to constrain inflammatory gene expression
- (2018) Tyrell N. Cartwright et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Distinct Compartmentalization of the Chemokines CXCL1 and CXCL2 and the Atypical Receptor ACKR1 Determine Discrete Stages of Neutrophil Diapedesis
- (2018) Tamara Girbl et al. IMMUNITY
- The diversity of circulating neutrophils in cancer
- (2017) Inbal Mishalian et al. IMMUNOBIOLOGY
- Introduction to checkpoint inhibitors and cancer immunotherapy
- (2017) Arlene H. Sharpe IMMUNOLOGICAL REVIEWS
- Immunotherapy in Non–Small Cell Lung Cancer Treatment
- (2017) Brett W. Carter et al. JOURNAL OF THORACIC IMAGING
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- PD-L1 expression in pleomorphic, spindle cell and giant cell carcinoma of the lung is related to TTF-1, p40 expression and might indicate a worse prognosis
- (2017) Violaine Yvorel et al. PLoS One
- Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies
- (2016) M. F. Sanmamed et al. ANNALS OF ONCOLOGY
- Next generation predictive biomarkers for immune checkpoint inhibition
- (2016) Yulian Khagi et al. CANCER AND METASTASIS REVIEWS
- Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments
- (2016) P. Zarzosa et al. Clinical & Translational Oncology
- From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung Cancers
- (2016) Adi F. Gazdar et al. Journal of Thoracic Oncology
- Immune Checkpoint Inhibitors in Non‐Small Cell Lung Cancer
- (2016) Benjamin Herzberg et al. ONCOLOGIST
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Neutrophil extracellular traps are indirectly triggered by lipopolysaccharide and contribute to acute lung injury
- (2016) Shuai Liu et al. Scientific Reports
- Pseudoprogression and Immune-Related Response in Solid Tumors
- (2015) Victoria L. Chiou et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer
- (2015) Antonio Calles et al. Journal of Thoracic Oncology
- MET is required for the recruitment of anti-tumoural neutrophils
- (2015) Veronica Finisguerra et al. NATURE
- Releasing the Brakes on Cancer Immunotherapy
- (2015) Antoni Ribas NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Advances in patient-derived tumor xenografts: From target identification to predicting clinical response rates in oncology
- (2014) Edward Rosfjord et al. BIOCHEMICAL PHARMACOLOGY
- PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
- (2014) A D'Incecco et al. BRITISH JOURNAL OF CANCER
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- Essential Role of Program Death 1-Ligand 1 in Regulatory T-Cell–Afforded Protection Against Blood–Brain Barrier Damage After Stroke
- (2014) Peiying Li et al. STROKE
- Regulation of Neuroinflammation through Programed Death-1/Programed Death Ligand Signaling in Neurological Disorders
- (2014) Shangfeng Zhao et al. Frontiers in Cellular Neuroscience
- Neutrophils as effector cells for antibody-based immunotherapy of cancer
- (2013) Marjolein van Egmond et al. SEMINARS IN CANCER BIOLOGY
- Tumor-associated neutrophils: friend or foe?
- (2012) Z. G. Fridlender et al. CARCINOGENESIS
- Patient-derived tumour xenografts as models for oncology drug development
- (2012) John J. Tentler et al. Nature Reviews Clinical Oncology
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody-Dependent Cell Cytotoxicity Synapses Form in Mice during Tumor-Specific Antibody Immunotherapy
- (2011) P. Hubert et al. CANCER RESEARCH
- On the dual roles and polarized phenotypes of neutrophils in tumor development and progression
- (2011) H. Piccard et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Targeting Fc RI on Polymorphonuclear Cells Induces Tumor Cell Killing through Autophagy
- (2011) J. E. Bakema et al. JOURNAL OF IMMUNOLOGY
- Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
- (2011) Yoko S DeRose et al. NATURE MEDICINE
- Antibodies in oncology
- (2011) Vinochani Pillay et al. New Biotechnology
- Patient-Derived First Generation Xenografts of Non-Small Cell Lung Cancers: Promising Tools for Predicting Drug Responses for Personalized Chemotherapy
- (2010) X. Dong et al. CLINICAL CANCER RESEARCH
- Neutrophils, from Marrow to Microbes
- (2010) Niels Borregaard IMMUNITY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now